Musbau Adewumi Akanji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Musbau Adewumi Akanji has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Mutiu Idowu Kazeem
Department of Biochemistry, Faculty of Science, Lagos State University, Ojo, Lagos, Nigeria
3 shared publications - Damilare Emmanuel Rotimi
Department of Biochemistry, Landmark University, Omu-Aran, Nigeria
2 shared publications - Oluwakemi Josephine Awakan
Landmark University, Omu-Aran, Nigeria
2 shared publications - Oluyomi Stephen Adeyemi
Department of Biochemistry, Medicinal Biochemistry, Nanomedicine & Toxicology Laboratory, Bowen University, Iwo, Nigeria
2 shared publications - Abdulazeez Olamilekan Elemosho
Department of Biological Sciences (Biochemistry Unit) Al‐Hikmah University Ilorin Nigeria
1 shared publication - Adedeji A Adelagun
Department of Animal Science, University of Ibadan , Ibadan
1 shared publication
Latest Publications
- Open Access
- 3 July 2026
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 61 (2)
Bioactive and nutraceutical characterization of moringa, Bambara groundnut, and yellow maize composites
This study evaluated composite flours formulated from Moringa oleifera leaf powder (8.07%–11.24%), Bambara groundnut (23%), and yellow maize (45%–61%) for their nutritional, antioxidant, and glycaemic-modulating properties. The composites exhibited enhanced protein (16.23%–17.57%), fibre (2.70%–3.24%), and ash (2.92%–3.77%). The pasting properties of the composites indicated improved paste stability and reduced retrogradation, characteristics favourable for reconstitutable and processed food applications. Bioactive compounds were significantly enriched: total phenolics (2.67–2.77 mg GAE/g), flavonoids (1.15–1.28 mg QE/g), and tannins (4.93–5.96 mg/g). Antioxidant activity improved across assays: 2,2-diphenyl-1-picrylhydrazyl (DPPH) SC50 (1.24–4.04 mg/ml), 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) SC50 (4.29–11.12 mg/ml), and Ferric ion reducing antioxidant power (FRAP) (2.21–2.46 mmol Fe²+/g). Enzyme inhibition was notable for α-amylase (IC50: 3.47–4.48 mg/ml) and α-glucosidase (1.17–2.05 mg/ml). These results support the potential of moringa–Bambara–maize composites as nutritionally enriched, functional food ingredients for managing oxidative stress and postprandial glycaemia.
- 3 July 2026
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 61 (2)
Open AccessBioactive and nutraceutical characterization of moringa, Bambara groundnut, and yellow maize composites
This study evaluated composite flours formulated from Moringa oleifera leaf powder (8.07%–11.24%), Bambara groundnut (23%), and yellow maize (45%–61%) for their nutritional, antioxidant, and glycaemic-modulating properties. The composites exhibited enhanced protein (16.23%–17.57%), fibre (2.70%–3.24%), and ash (2.92%–3.77%). The pasting properties of the composites indicated improved paste stability and reduced retrogradation, characteristics favourable for reconstitutable and processed food applications. Bioactive compounds were significantly enriched: total phenolics (2.67–2.77 mg GAE/g), flavonoids (1.15–1.28 mg QE/g), and tannins (4.93–5.96 mg/g). Antioxidant activity improved across assays: 2,2-diphenyl-1-picrylhydrazyl (DPPH) SC50 (1.24–4.04 mg/ml), 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) SC50 (4.29–11.12 mg/ml), and Ferric ion reducing antioxidant power (FRAP) (2.21–2.46 mmol Fe²+/g). Enzyme inhibition was notable for α-amylase (IC50: 3.47–4.48 mg/ml) and α-glucosidase (1.17–2.05 mg/ml). These results support the potential of moringa–Bambara–maize composites as nutritionally enriched, functional food ingredients for managing oxidative stress and postprandial glycaemia.
- 30 July 2023
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (9) , 7851-7865
Exploring redox imbalance and inflammation for asthma therapy
Background:Asthma is a prolonged inflammatory disorder of the airways, that affects an estimated 300 million people worldwide. Asthma is triggered by numerous endogenous and exogenous stimuli with symptoms like wheezing, cough, short of breath, chest tightening, airway obstruction, and hyperreactivity observed in patients. Objective: The review seeks to identify targets of redox imbalance and inflammation that could be explored to create effective treatments for asthma. Methods: The methodology involved a search and review of literature relating to asthma pathogenesis, redox homeostasis, and inflammation. Results: Eosinophils and neutrophils are involved in asthma pathogenesis. These inflammatory cells generate high levels of endogenous oxidants such as hydrogen peroxide and superoxide, which could result in redox imbalance in the airways of asthmatics. Redox imbalance occurs when the antioxidant systems becomes overwhelmed resulting in oxidative stress. Oxidative stress and inflammation have been linked with asthma inflammation and severity. Reactive oxygen species (ROS)/reactive nitrogen species (RNS) cause lung inflammation by activating nuclear factor kappa-B (NF-κB), mitogen-activated protein kinase (MAPK), activator protein-1, as well as additional transcription factors. These factors stimulate cytokine production which ultimately activates inflammatory cells in the bronchi, causing lung cellular injury and destruction. ROS/RNS is also produced by these inflammatory cells to eradicate invading bacteria. Antioxidant treatments for asthma have not yet been fully explored. Conclusion: Redox and inflammatory processes are viable targets that could be explored to create better therapy for asthma.
- 30 July 2023
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (9) , 7851-7865
Exploring redox imbalance and inflammation for asthma therapy
Background:Asthma is a prolonged inflammatory disorder of the airways, that affects an estimated 300 million people worldwide. Asthma is triggered by numerous endogenous and exogenous stimuli with symptoms like wheezing, cough, short of breath, chest tightening, airway obstruction, and hyperreactivity observed in patients. Objective: The review seeks to identify targets of redox imbalance and inflammation that could be explored to create effective treatments for asthma. Methods: The methodology involved a search and review of literature relating to asthma pathogenesis, redox homeostasis, and inflammation. Results: Eosinophils and neutrophils are involved in asthma pathogenesis. These inflammatory cells generate high levels of endogenous oxidants such as hydrogen peroxide and superoxide, which could result in redox imbalance in the airways of asthmatics. Redox imbalance occurs when the antioxidant systems becomes overwhelmed resulting in oxidative stress. Oxidative stress and inflammation have been linked with asthma inflammation and severity. Reactive oxygen species (ROS)/reactive nitrogen species (RNS) cause lung inflammation by activating nuclear factor kappa-B (NF-κB), mitogen-activated protein kinase (MAPK), activator protein-1, as well as additional transcription factors. These factors stimulate cytokine production which ultimately activates inflammatory cells in the bronchi, causing lung cellular injury and destruction. ROS/RNS is also produced by these inflammatory cells to eradicate invading bacteria. Antioxidant treatments for asthma have not yet been fully explored. Conclusion: Redox and inflammatory processes are viable targets that could be explored to create better therapy for asthma.
- Open Access
- 30 December 2022
- Published by Georg Thieme Verlag KG in Ibnosina Journal of Medicine and Biomedical Sciences
- Vol. 14 (04) , 145-151
Luffa cylindrica (Linn. M. J. Roem) Reduces Oxidative Stress In Vivo in Plasmodium berghei-Infected Albino Mice
Background Malaria is endemic in sub-Saharan Africa, and oxidative stress has been implicated in malaria disease. Luffa cylindrica is an ethnomedicinal plant used to treat various diseases, including malaria. The oxidative stress-reducing potential of L. cylindrica in malaria-disease state of Plasmodium berghei NK-65 parasite-infected mice was carried out in vivo.Materials and Methods Mice were infected with P. berghei NK-65, and the effect of administration of methanolic leaves extract (100, 200, and 400 mg/kg b.w) of L. cylindrica on percentage parasitemia in blood smear, antioxidant enzymes (catalase CAT, superoxide dismutase SOD, glutathione-s-transferase GST), non-enzymatic antioxidant (reduced glutathione GSH) and malondialdehyde concentration in tissues (plasma, liver, kidneys, and spleen) of mice was investigated and compared to chloroquine and artesunate as reference antimalarial drugs. Phytochemical constituents of the extract were determined by standard methods.Results Saponins, tannins, terpenes, phenolics, flavonoids, alkaloids, and glycosides were the phytochemical constituents identified in the extract. The extract at three doses (100, 200, and 400 mg/kg b.w.) investigated caused a significant reduction (p < 0.05) of parasite growth with over 90% reduction in parasitemia level in mice infected with the parasite. The extract also ameliorated oxidative stress in mice by significantly (p < 0.05) increasing the activities of CAT, SOD, and GST in the studied tissues of mice. The level of malondialdehyde, a marker of oxidative stress in mice, was also significantly (p < 0.05) reduced by the extract. The results were comparable with chloroquine- and artesunate-treated groups.Conclusion The study concludes that L. cylindrica is an effective therapy for treating malaria and for the management of its oxidative stress-related complications due to its antioxidant properties.
- 30 December 2022
- Published by Georg Thieme Verlag KG in Ibnosina Journal of Medicine and Biomedical Sciences
- Vol. 14 (04) , 145-151
Open AccessLuffa cylindrica (Linn. M. J. Roem) Reduces Oxidative Stress In Vivo in Plasmodium berghei-Infected Albino Mice
Background Malaria is endemic in sub-Saharan Africa, and oxidative stress has been implicated in malaria disease. Luffa cylindrica is an ethnomedicinal plant used to treat various diseases, including malaria. The oxidative stress-reducing potential of L. cylindrica in malaria-disease state of Plasmodium berghei NK-65 parasite-infected mice was carried out in vivo.Materials and Methods Mice were infected with P. berghei NK-65, and the effect of administration of methanolic leaves extract (100, 200, and 400 mg/kg b.w) of L. cylindrica on percentage parasitemia in blood smear, antioxidant enzymes (catalase CAT, superoxide dismutase SOD, glutathione-s-transferase GST), non-enzymatic antioxidant (reduced glutathione GSH) and malondialdehyde concentration in tissues (plasma, liver, kidneys, and spleen) of mice was investigated and compared to chloroquine and artesunate as reference antimalarial drugs. Phytochemical constituents of the extract were determined by standard methods.Results Saponins, tannins, terpenes, phenolics, flavonoids, alkaloids, and glycosides were the phytochemical constituents identified in the extract. The extract at three doses (100, 200, and 400 mg/kg b.w.) investigated caused a significant reduction (p < 0.05) of parasite growth with over 90% reduction in parasitemia level in mice infected with the parasite. The extract also ameliorated oxidative stress in mice by significantly (p < 0.05) increasing the activities of CAT, SOD, and GST in the studied tissues of mice. The level of malondialdehyde, a marker of oxidative stress in mice, was also significantly (p < 0.05) reduced by the extract. The results were comparable with chloroquine- and artesunate-treated groups.Conclusion The study concludes that L. cylindrica is an effective therapy for treating malaria and for the management of its oxidative stress-related complications due to its antioxidant properties.
- Open Access
- 8 September 2021
- Published by IntechOpen
The Two Sides of Dietary Antioxidants in Cancer Therapy
Cancer is a major cause of mortality around the world, representing about 13% of deaths on the planet. Among the available cancer treatments, chemotherapy is most frequently utilized compared to other treatments such as surgery and radiotherapy. Many dietary antioxidants have proven to effectively prevent oxidative stress, which has been noted in many disease pathogeneses, including cancer. However, during chemotherapy or radiotherapy treatment of cancer patients, antioxidants are used as an adjuvant treatment. The use of a proof-based technique is advised in determining the supplements most suited to cancer patients. Though there are numerous opinions about the dangers and advantages of antioxidants, it is reasonable to conclude that side effects caused by antioxidants, for now, remain unclear for patients during cancer treatment, aside from smokers during radiotherapy. In this report, details of the effectiveness of antioxidants on cancer treatment aiding in the reduction of cancer therapy side effects are discussed.
- 8 September 2021
- Published by IntechOpen
Open AccessThe Two Sides of Dietary Antioxidants in Cancer Therapy
Cancer is a major cause of mortality around the world, representing about 13% of deaths on the planet. Among the available cancer treatments, chemotherapy is most frequently utilized compared to other treatments such as surgery and radiotherapy. Many dietary antioxidants have proven to effectively prevent oxidative stress, which has been noted in many disease pathogeneses, including cancer. However, during chemotherapy or radiotherapy treatment of cancer patients, antioxidants are used as an adjuvant treatment. The use of a proof-based technique is advised in determining the supplements most suited to cancer patients. Though there are numerous opinions about the dangers and advantages of antioxidants, it is reasonable to conclude that side effects caused by antioxidants, for now, remain unclear for patients during cancer treatment, aside from smokers during radiotherapy. In this report, details of the effectiveness of antioxidants on cancer treatment aiding in the reduction of cancer therapy side effects are discussed.
- 1 March 2021
- Published by Taylor & Francis in International Journal of Vegetable Science
- Vol. 27 (6) , 552-560
Leafy vegetables inhibit activities of aldose reductase and sorbitol dehydrogenasein vitro
One of the processes involved in pathogenesis of diabetic complications is the polyol pathway, which is catalyzed by the enzymes – aldose reductase and sorbitol dehydrogenase. Inhibition of one, or both, of these enzymes will shut down the polyol pathway ameliorating diabetic complications. Consumption of leafy vegetables is a dietary regime for management of diabetes mellitus and its complications. Inhibitory effects of leafy vegetables on activities of the polyol pathway enzymes aldose reductase and sorbitol dehydrogenase, and mode(s) of inhibition of these enzymes by the most effective plant were evaluated. Aqueous extract of leaves of African eggplant (Solanum macrocarpon L), bitter leaf (Vernonia amygdalina Del.), fluted pumpkin (Telfairia occidentalis Hook.) and clove basil leaf (Ocimum gratissimum L), were incubated with substrates (glucose and sorbitol) and enzymes, and their percent inhibition of enzymes determined spectrophotometrically. Due to low IC50 value, the aqueous extract of bitter leaf was used to assess kinetics of both enzymes. With exception of African eggplant, all plants displayed stronger inhibition of sorbitol dehydrogenase than aldose reductase. Vernonia amygdalina exhibited the lowest IC50 for aldose reductase (78.03 µg∙mL−1) and sorbitol dehydrogenase (22.17 µg∙mL−1). Vernonia amygdalina inhibited aldose reductase and sorbitol dehydrogenase in a noncompetitive, and mixed non-competitive manner, respectively. The V. amygdalina extract displayed potent inhibition of polyol pathway enzymes, and it needs to be determined if consumption affects the responses.
- 1 March 2021
- Published by Taylor & Francis in International Journal of Vegetable Science
- Vol. 27 (6) , 552-560
Leafy vegetables inhibit activities of aldose reductase and sorbitol dehydrogenasein vitro
One of the processes involved in pathogenesis of diabetic complications is the polyol pathway, which is catalyzed by the enzymes – aldose reductase and sorbitol dehydrogenase. Inhibition of one, or both, of these enzymes will shut down the polyol pathway ameliorating diabetic complications. Consumption of leafy vegetables is a dietary regime for management of diabetes mellitus and its complications. Inhibitory effects of leafy vegetables on activities of the polyol pathway enzymes aldose reductase and sorbitol dehydrogenase, and mode(s) of inhibition of these enzymes by the most effective plant were evaluated. Aqueous extract of leaves of African eggplant (Solanum macrocarpon L), bitter leaf (Vernonia amygdalina Del.), fluted pumpkin (Telfairia occidentalis Hook.) and clove basil leaf (Ocimum gratissimum L), were incubated with substrates (glucose and sorbitol) and enzymes, and their percent inhibition of enzymes determined spectrophotometrically. Due to low IC50 value, the aqueous extract of bitter leaf was used to assess kinetics of both enzymes. With exception of African eggplant, all plants displayed stronger inhibition of sorbitol dehydrogenase than aldose reductase. Vernonia amygdalina exhibited the lowest IC50 for aldose reductase (78.03 µg∙mL−1) and sorbitol dehydrogenase (22.17 µg∙mL−1). Vernonia amygdalina inhibited aldose reductase and sorbitol dehydrogenase in a noncompetitive, and mixed non-competitive manner, respectively. The V. amygdalina extract displayed potent inhibition of polyol pathway enzymes, and it needs to be determined if consumption affects the responses.
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Reactive species, such as those of oxygen, nitrogen, and sulfur, are considered part of normal cellular metabolism and play significant roles that can impact several signaling processes in ways that lead to either cellular sustenance, protection, or damage. Cellular redox processes involve a balance in the production of reactive species (RS) and their removal because redox imbalance may facilitate oxidative damage. Physiologically, redox homeostasis is essential for the maintenance of many cellular processes. RS may serve as signaling molecules or cause oxidative cellular damage depending on the delicate equilibrium between RS production and their efficient removal through the use of enzymatic or nonenzymatic cellular mechanisms. Moreover, accumulating evidence suggests that redox imbalance plays a significant role in the progression of several neurodegenerative diseases. For example, studies have shown that redox imbalance in the brain mediates neurodegeneration and alters normal cytoprotective responses to stress. Therefore, this review describes redox homeostasis in neurodegenerative diseases with a focus on Alzheimer’s and Parkinson’s disease. A clearer understanding of the redox‐regulated processes in neurodegenerative disorders may afford opportunities for newer therapeutic strategies.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessRedox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Reactive species, such as those of oxygen, nitrogen, and sulfur, are considered part of normal cellular metabolism and play significant roles that can impact several signaling processes in ways that lead to either cellular sustenance, protection, or damage. Cellular redox processes involve a balance in the production of reactive species (RS) and their removal because redox imbalance may facilitate oxidative damage. Physiologically, redox homeostasis is essential for the maintenance of many cellular processes. RS may serve as signaling molecules or cause oxidative cellular damage depending on the delicate equilibrium between RS production and their efficient removal through the use of enzymatic or nonenzymatic cellular mechanisms. Moreover, accumulating evidence suggests that redox imbalance plays a significant role in the progression of several neurodegenerative diseases. For example, studies have shown that redox imbalance in the brain mediates neurodegeneration and alters normal cytoprotective responses to stress. Therefore, this review describes redox homeostasis in neurodegenerative diseases with a focus on Alzheimer’s and Parkinson’s disease. A clearer understanding of the redox‐regulated processes in neurodegenerative disorders may afford opportunities for newer therapeutic strategies.
- Open Access
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 3439048
Leaf Extracts of Aerva lanata Inhibit the Activities of Type 2 Diabetes‐Related Enzymes and Possess Antioxidant Properties
The leaves of Aerva lanata are one of the indigenous medicinal plants used in the management of diabetes mellitus and its associated complications in Africa. However, its effect on the activities of diabetes‐related enzymes has not been investigated. This study evaluated the in vitro inhibitory effects of different extracts of the A. lanata leaf on the activities of diabetes‐related enzymes (α‐amylase and α‐glucosidase) and chemically induced free radicals. Aqueous, ethanol, and hydroethanol extracts of A. lanata leaves were subjected to a standard enzyme inhibition assay followed by determination of modes of inhibition of the enzymes. The antioxidant activities of the extracts were evaluated using 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) and 2,2‐azino‐bis‐(3‐ethylbenzothiazoline‐6‐sulphonic acid) (ABTS). The results obtained showed that the hydroethanol extract of the A. lanata leaf optimally inhibited both α‐amylase (IC50: 2.42 mg/mL) and α‐glucosidase (IC50: 0.23 mg/mL). The Lineweaver‐Burk plot revealed that the mode of inhibition of both enzymes by the hydroethanol extract was uncompetitive. However, the hydroethanol and aqueous extracts displayed the best DPPH and ABTS radical‐scavenging ability, respectively. It can be concluded that the A. lanata extract inhibited the activities of both α‐amylase and α‐glucosidase uncompetitively, which may be attributed to its free radical‐scavenging properties and rich phenolic composition.
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 3439048
Open AccessLeaf Extracts of Aerva lanata Inhibit the Activities of Type 2 Diabetes‐Related Enzymes and Possess Antioxidant Properties
The leaves of Aerva lanata are one of the indigenous medicinal plants used in the management of diabetes mellitus and its associated complications in Africa. However, its effect on the activities of diabetes‐related enzymes has not been investigated. This study evaluated the in vitro inhibitory effects of different extracts of the A. lanata leaf on the activities of diabetes‐related enzymes (α‐amylase and α‐glucosidase) and chemically induced free radicals. Aqueous, ethanol, and hydroethanol extracts of A. lanata leaves were subjected to a standard enzyme inhibition assay followed by determination of modes of inhibition of the enzymes. The antioxidant activities of the extracts were evaluated using 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) and 2,2‐azino‐bis‐(3‐ethylbenzothiazoline‐6‐sulphonic acid) (ABTS). The results obtained showed that the hydroethanol extract of the A. lanata leaf optimally inhibited both α‐amylase (IC50: 2.42 mg/mL) and α‐glucosidase (IC50: 0.23 mg/mL). The Lineweaver‐Burk plot revealed that the mode of inhibition of both enzymes by the hydroethanol extract was uncompetitive. However, the hydroethanol and aqueous extracts displayed the best DPPH and ABTS radical‐scavenging ability, respectively. It can be concluded that the A. lanata extract inhibited the activities of both α‐amylase and α‐glucosidase uncompetitively, which may be attributed to its free radical‐scavenging properties and rich phenolic composition.
- Open Access
- 28 June 2013
- Published by Fountain University in Fountain Journal of Natural and Applied Sciences
- Vol. 2 (1)
Safety Evaluation of Aqueous Extract of Crateva adansonii Leaves on Selected Tissues of Rats
The phytochemical constituents and safety of aqueous extract of Crateva adansonii leaves on rats were investigated. Forty rats were grouped into 4 (A-D) of 10 animals each. Group A rats received 1 mL of distilled water, while groups B, C and D received equal volume corresponding to 325, 650 and 1300 mg/kg body weight of the extract, respectively, for seven days. Five rats were sacrificed from each group 24 h after 7 doses, while the remaining five were sacrificed 24 h after discontinuing the administration for another 7 days (recovery period, day 14). Phytochemical screening revealed the presence of saponins (2.36%), alkaloids (1.34%), tannins (0.94%), phenolics (1.06%), flavonoids (0.09%), phlobatannins (0.54%) and anthraquinones (0.47%). The extract significantly increased (P0.05) with their respective controls. In contrast, the increases in the serum total protein, ALP and AST as well as decreases in liver alanine aminotransferase (ALT), serum chloride and sodium ions were sustained during the recovery period. Furthermore, the levels of serum albumin, total and conjugated bilirubin, urea, creatinine, potassium, bicarbonate, haematological parameters and computed organ-body weight ratios were not significantly (p>0.05) altered. The histology of the kidney and small intestine were preserved whereas there was mild degeneration and congestion of the hepatocytes surrounding the central veins in the liver. Overall, the extract caused mild, selective and reversible changes in the haematological profile and biochemical parameters of organ function. Therefore, because the rats recovered from the assault of the extract, the plant may still be explored as oral remedy.
- 28 June 2013
- Published by Fountain University in Fountain Journal of Natural and Applied Sciences
- Vol. 2 (1)
Open AccessSafety Evaluation of Aqueous Extract of Crateva adansonii Leaves on Selected Tissues of Rats
The phytochemical constituents and safety of aqueous extract of Crateva adansonii leaves on rats were investigated. Forty rats were grouped into 4 (A-D) of 10 animals each. Group A rats received 1 mL of distilled water, while groups B, C and D received equal volume corresponding to 325, 650 and 1300 mg/kg body weight of the extract, respectively, for seven days. Five rats were sacrificed from each group 24 h after 7 doses, while the remaining five were sacrificed 24 h after discontinuing the administration for another 7 days (recovery period, day 14). Phytochemical screening revealed the presence of saponins (2.36%), alkaloids (1.34%), tannins (0.94%), phenolics (1.06%), flavonoids (0.09%), phlobatannins (0.54%) and anthraquinones (0.47%). The extract significantly increased (P0.05) with their respective controls. In contrast, the increases in the serum total protein, ALP and AST as well as decreases in liver alanine aminotransferase (ALT), serum chloride and sodium ions were sustained during the recovery period. Furthermore, the levels of serum albumin, total and conjugated bilirubin, urea, creatinine, potassium, bicarbonate, haematological parameters and computed organ-body weight ratios were not significantly (p>0.05) altered. The histology of the kidney and small intestine were preserved whereas there was mild degeneration and congestion of the hepatocytes surrounding the central veins in the liver. Overall, the extract caused mild, selective and reversible changes in the haematological profile and biochemical parameters of organ function. Therefore, because the rats recovered from the assault of the extract, the plant may still be explored as oral remedy.
- Open Access
- 1 May 2013
- Published by Science Alert in Journal of Medical Sciences
- Vol. 13 (4) , 253-260
Hypolipidemic and Toxicological Potential of Aqueous Extract of Rauvolfia vomitoria Afzel Root in Wistar Rats
- 1 May 2013
- Published by Science Alert in Journal of Medical Sciences
- Vol. 13 (4) , 253-260
Open AccessHypolipidemic and Toxicological Potential of Aqueous Extract of Rauvolfia vomitoria Afzel Root in Wistar Rats